| Literature DB >> 25960645 |
De-Zhao Wang1, Wei Chen1, Song Yang2, Jun Wang3, Qun Li1, Qiang Fu2, Shi-Jing Li3, Bu-Xing Chen1.
Abstract
OBJECTIVE: To explore the relationship between Helicobacter pylori (Hp) infection and atrial fibrillation (AF) in Chinese patients.Entities:
Keywords: 13C urea breath test; high sensitivity C-reactive protein; left atrial diameter
Mesh:
Substances:
Year: 2015 PMID: 25960645 PMCID: PMC4423503 DOI: 10.2147/CIA.S72724
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
The baseline data of each group
| Group | Control group (n=300) | AF group
| |||
|---|---|---|---|---|---|
| Short-standing AF group (n=126) | Long-standing AF group (n=159) | ||||
| Female, n | 198 (66.0%) | 82 (65.1%) | 93 (58.5%) | 0.256 | 0.265 |
| Smoke, n | 159 (53.0%) | 66 (52.4%) | 81 (50.9%) | 0.809 | 0.916 |
| Alcohol, n | 89 (29.7%) | 43 (34.1%) | 54 (34.0%) | 0.977 | 0.525 |
| Hypertension, n | 221 (73.7%) | 99 (78.6%) | 121 (76.1%) | 0.622 | 0.546 |
| Dyslipidemia, n | 112 (37.3%) | 55 (43.7%) | 62 (39.0%) | 0.427 | 0.475 |
| Diabetes mellitus, n | 90 (30.0%) | 32 (25.4%) | 54 (34.0%) | 0.118 | 0.293 |
| Cerebral infarction, n | 82 (27.3%) | 37 (29.4%) | 54 (34%) | 0.408 | 0.334 |
| Hematencephalon, n | 7 (1.2%) | 5 (0.9%) | 4 (0.7%) | 0.486 | 0.628 |
| Family history of AF, n | 11 (3.7%) | 7 (5.6%) | 5 (3.1%) | 0.314 | 0.550 |
| Arteriosclerosis, n | 190 (63.3%) | 85 (67.5%) | 116 (73.0%) | 0.312 | 0.113 |
| Fundus abnormal, n | 268 (89.3%) | 112 (88.9%) | 135 (84.9%) | 0.462 | 0.205 |
| Mean age ± SD (years) | 60.2±10.65 | 62.1±11.78 | 65.1±9.80 | 0.022 | <0.001 |
| Mean SBP ± SD (mmHg) | 135±22.3 | 132±23.1 | 136±22.3 | 0.235 | 0.478 |
| Mean heart rate/minute | 74±12.3 | 76±16.0 | 79±14.5 | 0.019 | <0.001 |
| Mean WBC ± SD (109/L) | 7.3±2.30 | 7.4±2.50 | 7.4±2.53 | 0.851 | 0.919 |
| Mean NEU ± SD (109/L) | 4.9±1.44 | 5.3±1.60 | 6.3±2.19 | <0.001 | <0.001 |
| Mean LVEF ± SD (%) | 61.4±10.13 | 61.9±10.80 | 60.8±10.55 | 0.363 | 0.654 |
| Mean LAD ± SD (mm) | 32.9±4.45 | 34.8±4.79 | 36.7±5.86 | 0.001 | <0.001 |
| Mean BMI ± SD (kg/m2) | 25.5±3.88 | 25.2±3.41 | 25.4±4.16 | 0.673 | 0.681 |
| Median hs-CRP (mg/L) (interquartile range) | 8.00 (5.34–12.00) | 8.00 (4.87–13.29) | 12.60 (7.60–24.00) | 0.002 | 0.003 |
| Median HCY (μmol/L) (interquartile range) | 9.90 (4.57–16.10) | 11.90 (9.76–17.20) | 12.60 (10.12–20.10) | 0.005 | <0.001 |
| Hp-IgG antibody | 131 (43.7%) | 60 (47.6%) | 79 (49.7%) | 0.238 | 0.437 |
| Hp | 6.25 (2.10–13.30) | 7.00 (2.10–14.50) | 19.00 (8.00–26.00) | <0.001 | <0.001 |
| Hp | 86 (28.7%) | 31 (24.6%) | 130 (81.8%) | <0.001 | <0.001 |
Abbreviations: AF, atrial fibrillation; SD, standard deviation; SBP, systolic blood pressure; WBC, white blood-cell count; NEU, neutrophil; LVEF, left ventricular ejection fraction; LAD, left atrium diameter; BMI, body mass index; hs-CRP, high sensitive C-reactive protein; HCY, homocysteine; Hp, Helicobacter pylori.
Figure 1Comparison of Hp-positive/Hp-negative and Hp-IgG antibody-positive/Hp-IgG antibody-negative among the groups.
Abbreviations: Hp, Helicobacter pylori; AF, atrial fibrillation.
Figure 2Comparison of Hp levels among the groups (P<0.001).
Notes: The Hp levels on admission were significantly higher in the long-standing AF group than in the short-standing AF group and control group (P<0.001, P<0.001, respectively).
Abbreviations: Hp, Helicobacter pylori; AF, atrial fibrillation.
Comparing Hp δ value, hs-CRP, and LAD among five groups of AF
| Group | Types of AF | n | Hp | hs-CRP (mg/L) | LAD ± SD (mm) |
|---|---|---|---|---|---|
| 1 | Initial AF | 34 | 6.35 (1.8–11.4) | 4.30 (1.84–8.01) | 35.9±3.80 |
| 2 | Paroxysmal AF | 58 | 5.25 (1.67–19.3) | 5.58 (3.89–10.27) | 37.1±4.64 |
| 3 | Persistent AF | 67 | 8.40 (2.50–19.0) | 4.94 (2.50–11.56) | 37.3±4.54 |
| 4 | Long persistent AF | 76 | 8.10 (2.43–30.4) | 5.83 (2.36–14.41) | 37.6±5.16 |
| 5 | Permanent AF | 50 | 14.9 (4.13–31.0) | 6.81 (5.25–16.68) | 39.5±5.75 |
Notes:
Patients with permanent AF in Group 5 had a significantly higher Hp level than those in Group 1, 2, and 3.
The median hs-CRP value of Group 5 was significantly higher than those of Group 1, 2, and 3.
The mean LAD value in Group 5 was significantly higher than those in Group 1, 2, 3, and 4.
Abbreviations: Hp, Helicobacter pylori; hs-CRP, high sensitive C-reactive protein; LAD, left atrial diameter; AF, atrial fibrillation; SD, standard deviation.
Predictors of presence of long-standing AF in logistic regression analysis
| Variable | Univariate
| Multivariate
| ||
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||
| Age | 1.040 (1.021–1.058) | <0.001 | 1.021 (0.997–1.045) | 0.090 |
| Smoke | 0.928 (0.644–1.336) | 0.687 | 0.956 (0.570–1.603) | 0.864 |
| Hypertension | 1.055 (0.689–1.614) | 0.806 | 1.117 (0.634–1.969) | 0.701 |
| Dyslipidemia | 0.991 (0.682–1.440) | 0.963 | 0.897 (0.538–1.497) | 0.687 |
| Diabetes mellitus | 1.281 (0.868–1.892) | 0.212 | 1.662 (0.352–7.845) | 0.521 |
| Cerebral infarction | 1.327 (0.898–1.961) | 0.156 | 0.592 (0.123–2.844) | 0.513 |
| Hematencephalon | 0.890 (0.283–2.802) | 0.843 | 2.805 (0.184–42.752) | 0.458 |
| Family history of AF | 0.736 (0.269–2.017) | 0.551 | 0.458 (0.042–5.020) | 0.523 |
| Arteriosclerosis | 1.351 (0.917–1.991) | 0.128 | 1.563 (0.943–2.592) | 0.083 |
| HR >100 bpm | 2.492 (1.310–4.742) | 0.005 | 1.927 (0.807–4.602) | 0.140 |
| NEU >8×109/L | 5.730 (3.192–10.285) | <0.001 | 4.863 (2.338–10.113) | <0.001 |
| LAD >36 mm | 2.401 (1.656–3.481) | <0.001 | 2.469 (1.526–3.996) | <0.001 |
| Hs-CRP >5 mg/L | 2.069 (1.338–3.201) | 0.001 | 2.458 (1.406–4.298) | 0.002 |
| Hp | 11.724 (7.435–18.487) | <0.001 | 13.172 (7.819–22.191) | <0.001 |
| HCY ≥15 μmol/L | 2.902 (1.993–4.226) | <0.001 | 3.203 (1.983–5.173) | <0.001 |
Abbreviations: AF, atrial fibrillation; OR, odds ratio; CI, confidence interval; HR, heart rate; NEU, neutrophil; LAD, left atrial diameter; hs-CRP, high sensitive C-reactive protein; Hp, Helicobacter pylori; HCY, homocysteine.
Contingency table for Hosmer and Lemeshow test
| Short-standing AF
| Long-standing AF
| Total | ||
|---|---|---|---|---|
| Observed | Expected | Observed | Expected | |
| 58 | 59.175 | 2 | 0.825 | 60 |
| 57 | 57.403 | 2 | 1.597 | 59 |
| 58 | 56.585 | 1 | 2.415 | 59 |
| 52 | 55.124 | 7 | 3.876 | 59 |
| 53 | 52.693 | 6 | 6.307 | 59 |
| 50 | 48.439 | 9 | 10.561 | 59 |
| 45 | 41.317 | 15 | 18.683 | 60 |
| 32 | 30.481 | 27 | 28.519 | 59 |
| 17 | 18.094 | 42 | 40.906 | 59 |
| 4 | 6.689 | 48 | 45.311 | 52 |
Abbreviation: AF, atrial fibrillation.
Figure 3The ROC curves analysis of Hp infection, LAD, NEU, hs-CRP, HCY, and multivariate variables for predicting long-standing AF.
Abbreviations: ROC, receiver-operating characteristic; Hp, Helicobacter pylori; LAD, left atrial diameter; NEU, neutrophil; hs-CRP, high sensitive C-reactive protein; HCY, homocysteine; AF, atrial fibrillation.
AUC, Se, and Sp
| Test result variable | Area under curve
| Se (95% CI) | Sp (95% CI) | The best critical value | |
|---|---|---|---|---|---|
| AUC (95% CI) | |||||
| Multivariate variables | 0.879 (0.847–0.912) | <0.001 | 0.767 (0.733–0.801) | 0.850 (0.821–0.879) | 0.359 |
| Hp | 0.774 (0.729–0.820) | <0.001 | 0.667 (0.629–0.705) | 0.784 (0.751–0.817) | 14.75 |
| NEU (109/L) | 0.669 (0.619–0.720) | <0.001 | 0.509 (0.468–0.550) | 0.765 (0.731–0.799) | 6.25 |
| HCY (μmol/L) | 0.655 (0.608–0.702) | <0.001 | 0.541 (0.501–0.581) | 0.657 (0.619–0.695) | 12.52 |
| hs-CRP (mg/L) | 0.694 (0.643–0.745) | <0.001 | 0.447 (0.407–0.487) | 0.934 (0.914–0.954) | 21.15 |
| LAD (mm) | 0.662 (0.610–0.714) | <0.001 | 0.535 (0.495–0.575) | 0.796 (0.763–0.829) | 37.10 |
Abbreviations: AUC, area under curve; Se, sensitivity; Sp, specificity; CI, confidence interval; Hp, Helicobacter pylori; NEU, neutrophil; HCY, homocysteine; hs-CRP, high sensitive C-reactive protein; LAD, left atrial diameter.